Swiss pharma company Roche is buying Flatiron Health for $1.9 billion


Roche, the global pharmaceutical company from Switzerland today announced it will scoop up Flatiron Health, a startup analyzing real-time oncology data to help cancer patients and doctors in a $1.9 billion deal.

Flatiron has also confirmed the deal in a tweet.

Two years ago, Roche led a $175 million deal in the startup at a $1.2 billion valuation. At the time of the deal, Roche agreed to buy several of Flatiron’s subscription-based software products,…

Read Story